Health & Beauty

In 2022, with the effective control of the global COVID-19, the volume of import and export trade will grow rapidly, reaching a new high in recent three years. In 2023, the customs clearance trade of countries around the world will gradually recover, and what will happen to the market of imported products?

1、 Looking back on the gradual recovery of import and export trade in 2022, the market was relatively stable.

Significant import and export increment in 2022

From the fourth quarter of 2021, the border trade of various countries gradually recovered, and the import volume of Chinese traditional medicine raw materials began to increase steadily. According to customs data, in 2022, China's total imports of traditional Chinese medicine reached 132300 tons, an increase of 95.42% compared with 2021. From 2021 to 2022, China's total exports of traditional Chinese medicine increased steadily, and the export volume of raw materials of traditional Chinese medicine remained above 6000 tons/month, with good overall performance. On the one hand, border trade has gradually returned to normal; On the other hand, countries around the world are actively engaged in trade exchanges, driving significant growth in trade among countries. According to customs data, China's total export of raw materials of traditional Chinese medicine will reach 135000 tons in 2022, an increase of 7.14% compared with 2021. The import and export trade volume of Chinese medicinal materials has increased significantly, making the industry full of confidence in the import and export trade of Chinese medicinal materials in 2023.

Customs clearance trade resumed and enterprises' willingness to purchase strengthened

In 2022, the purchasing managers' index of traditional Chinese medicine closed at 58.16, significantly warmer than that in 2021, and the production of traditional Chinese medicine industry began to rebound from the trough.

According to customs data, in the first quarter, due to the control of epidemic situation around the Spring Festival in 2022, the production and demand of traditional Chinese medicine were greatly limited, and the inventory backlog and the decline of import and export orders, the purchasing manager index of traditional Chinese medicine fell slightly, from 58.99 in January 2022 to 58.89 in March 2021, down 0.17%.

The second quarter: after March 2022, the production and demand of traditional Chinese medicine increased, and the purchasing willingness of enterprises strengthened. The purchasing manager index began to rise sharply, from 58.89 in March to 60.69 in April, up 3.06%. Subsequently, due to the surge in the production capacity of most traditional Chinese medicine raw materials, the production of new varieties led to the rapid correction of the market of traditional Chinese medicine, and the weakening of the purchasing willingness of enterprises, the purchasing manager index fell, from 60.69 in April to 57.53 in June, down 5.21%.

In the third quarter, affected by the continuous high temperature and drought in the Yangtze River basin, the unit yield of some traditional Chinese medicine raw materials decreased significantly. Peripheral capital and hot money quickly entered the field of traditional Chinese medicine raw materials, driving the purchasing managers' index to rebound slightly, from 57.96 in July to 59.29 in October, up 2.29%.

The fourth quarter: customs data showed that from October to November, the raw materials of traditional Chinese medicine were intensively produced, the production capacity of some varieties increased sharply, and the purchasing willingness of enterprises weakened. The purchasing managers' index of traditional Chinese medicine fell from 58.57 in October to 57.38 in November, down 2.03%; In December, due to the change of epidemic prevention policy, the social consumption demand for anti-epidemic Chinese medicinal materials, Chinese herbal decoction pieces and Chinese patent medicines increased sharply in the short term, and the purchasing manager index rose slightly. The purchasing manager index in December was 58.16, up 1.36% from November.

The number of imported varieties with abnormal market in 2022 will decrease

According to the customs data, in 2022, the varieties with the fluctuation range of import raw materials>100% accounted for 1.72%, down 12.07% from 2021; The varieties with the fluctuation range of 20% - 50% in the market of imported raw materials accounted for 25.86%, an increase of 10.34% over 2021.